Well over 4,000 delegates attend DPC2018
Well over 4,000 delegates attended this year’s Diabetes Professional Care (DPC2018), the organisers have confirmed.
The record-breaking figure has exceeded last year’s total of 3,235 delegates. Only in its fourth year, DPC2018 is the UK’s only national, free-to-attend and CPD-accredited conference for those involved in the prevention, treatment and management of diabetes, and its related conditions. It has become the best attended event for healthcare professionals working in the field.
It kicked off on November 14, World Diabetes Day at London’s Olympia with a keynote speech delivered by Professor Jonathan Valabhji, NHS England’s National Clinical Director for Obesity and Diabetes and Dr Partha Kar, Diabetes Consultant and National Associate Clicnical Director for Diabetes.
The results of the eagerly-anticipated DECLARE study into cardiovascular disease and type 2 diabetes were unveiled for the first time and the very first DPC Industry Awards took place, which celebrated excellence among companies and organisations within diabetes.
Founder Maggie Meer, who has type 2 diabetes and set up the conference in a bid to improve care, said: “It’s massively exciting that DPC has developed so much since we started and now people are using our annual event as a platform to launch research findings, products, data and examples of best practice in diabetes. DPC is at the heart of sharing best practice and tackling subjects that need to be addressed in diabetes.”
Commenting on the rise of DPC, Oliver Jelley, Editor of The Diabetes Times, said: “DPC has quickly become a force for good in diabetes care in the UK, with the conference acting like a platform to share best practice and innovation across the NHS to improve care for people with diabetes.”
Day two of the event was dominated by the Live Debate where four leading policymakers and clinicians discussed the vest way to tackle childhood obesity.
There was also talks on individualising diabetes care for older people with a focus on frailty delivered by Professor Alan Sinclair, Director of Diabetes Frail and the Foundation for Diabetes Research in Older People (FDROP) and Dr Kevin Fernando, a GP from Scotland, discussed biosimilars.
The subject of safer acute care for people with diabetes was approached by Dr Mayank Patel, a Consultant in Diabetes and Senior Clinical Lecturer at University Hospital Southampton NHS Trust and University of Southampton.